

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | blood vessel maturation (GO:0001955) | 5.73999078 |
| 2 | negative regulation of telomerase activity (GO:0051974) | 5.39731254 |
| 3 | dermatan sulfate biosynthetic process (GO:0030208) | 5.22887778 |
| 4 | regulation of neuron projection regeneration (GO:0070570) | 5.04485429 |
| 5 | regulation of axon regeneration (GO:0048679) | 5.04485429 |
| 6 | positive regulation of natural killer cell differentiation (GO:0032825) | 5.03019577 |
| 7 | definitive hemopoiesis (GO:0060216) | 5.00108314 |
| 8 | dermatan sulfate metabolic process (GO:0030205) | 5.00043046 |
| 9 | collagen fibril organization (GO:0030199) | 4.79620381 |
| 10 | mesenchymal-epithelial cell signaling (GO:0060638) | 4.70502935 |
| 11 | phospholipid scrambling (GO:0017121) | 4.43850941 |
| 12 | chondrocyte proliferation (GO:0035988) | 4.37906879 |
| 13 | * chondroitin sulfate biosynthetic process (GO:0030206) | 4.28623044 |
| 14 | response to gravity (GO:0009629) | 4.06987706 |
| 15 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.89697066 |
| 16 | protein heterotrimerization (GO:0070208) | 3.86484714 |
| 17 | neuron remodeling (GO:0016322) | 3.75825308 |
| 18 | mitochondrial genome maintenance (GO:0000002) | 3.72435126 |
| 19 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.62911007 |
| 20 | regulation of natural killer cell differentiation (GO:0032823) | 3.54459412 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.52240973 |
| 22 | negative regulation of cell killing (GO:0031342) | 3.52240973 |
| 23 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.49186394 |
| 24 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.46189712 |
| 25 | phagocytosis, recognition (GO:0006910) | 3.35187424 |
| 26 | fibril organization (GO:0097435) | 3.34719498 |
| 27 | cellular response to ethanol (GO:0071361) | 3.34339630 |
| 28 | positive regulation of extracellular matrix organization (GO:1903055) | 3.33150612 |
| 29 | bone trabecula formation (GO:0060346) | 3.30608130 |
| 30 | regulation of telomerase activity (GO:0051972) | 3.30596025 |
| 31 | cartilage morphogenesis (GO:0060536) | 3.29773760 |
| 32 | phagocytosis, engulfment (GO:0006911) | 3.28584495 |
| 33 | virion attachment to host cell (GO:0019062) | 3.26950875 |
| 34 | adhesion of symbiont to host cell (GO:0044650) | 3.26950875 |
| 35 | cartilage condensation (GO:0001502) | 3.23869399 |
| 36 | cell aggregation (GO:0098743) | 3.23869399 |
| 37 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 3.22576246 |
| 38 | endothelial cell morphogenesis (GO:0001886) | 3.20955180 |
| 39 | chondroitin sulfate catabolic process (GO:0030207) | 3.16587422 |
| 40 | platelet dense granule organization (GO:0060155) | 3.16472200 |
| 41 | lymph vessel development (GO:0001945) | 3.15626507 |
| 42 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.14553629 |
| 43 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.14458499 |
| 44 | mature B cell differentiation involved in immune response (GO:0002313) | 3.13970127 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.12839447 |
| 46 | chondrocyte development (GO:0002063) | 3.11605122 |
| 47 | extracellular fibril organization (GO:0043206) | 3.10756833 |
| 48 | cellular response to epinephrine stimulus (GO:0071872) | 3.10560660 |
| 49 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.09279652 |
| 50 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.04827251 |
| 51 | regulation of regulatory T cell differentiation (GO:0045589) | 3.01550004 |
| 52 | mRNA transcription (GO:0009299) | 2.98404886 |
| 53 | negative regulation of type 2 immune response (GO:0002829) | 2.97910475 |
| 54 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.95950919 |
| 55 | collagen metabolic process (GO:0032963) | 2.94820284 |
| 56 | response to interleukin-15 (GO:0070672) | 2.94300885 |
| 57 | mitochondrial DNA replication (GO:0006264) | 2.93761784 |
| 58 | collagen catabolic process (GO:0030574) | 2.91339993 |
| 59 | negative T cell selection (GO:0043383) | 2.89893928 |
| 60 | keratan sulfate catabolic process (GO:0042340) | 2.89702462 |
| 61 | positive thymic T cell selection (GO:0045059) | 2.89620487 |
| 62 | cellular extravasation (GO:0045123) | 2.89170361 |
| 63 | negative thymic T cell selection (GO:0045060) | 2.88162924 |
| 64 | response to interferon-alpha (GO:0035455) | 2.87836059 |
| 65 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.86810283 |
| 66 | L-fucose catabolic process (GO:0042355) | 2.86365670 |
| 67 | fucose catabolic process (GO:0019317) | 2.86365670 |
| 68 | L-fucose metabolic process (GO:0042354) | 2.86365670 |
| 69 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.83857671 |
| 70 | response to epinephrine (GO:0071871) | 2.81867657 |
| 71 | galactose metabolic process (GO:0006012) | 2.78323392 |
| 72 | peptidyl-proline hydroxylation (GO:0019511) | 2.78310883 |
| 73 | negative regulation of biomineral tissue development (GO:0070168) | 2.76559038 |
| 74 | regulation of tight junction assembly (GO:2000810) | 2.74418741 |
| 75 | positive T cell selection (GO:0043368) | 2.73883390 |
| 76 | negative regulation of complement activation (GO:0045916) | 2.70145850 |
| 77 | nuclear envelope reassembly (GO:0031468) | 2.69387360 |
| 78 | mitotic nuclear envelope reassembly (GO:0007084) | 2.69387360 |
| 79 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.69145528 |
| 80 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.68968576 |
| 81 | regulation of relaxation of muscle (GO:1901077) | 2.67498767 |
| 82 | secretory granule organization (GO:0033363) | 2.67476073 |
| 83 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.67430904 |
| 84 | negative regulation of fatty acid transport (GO:2000192) | 2.66976083 |
| 85 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.66816778 |
| 86 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.65867352 |
| 87 | megakaryocyte development (GO:0035855) | 2.65153641 |
| 88 | negative regulation of stress fiber assembly (GO:0051497) | 2.64118229 |
| 89 | protein retention in ER lumen (GO:0006621) | 2.64110131 |
| 90 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.62239801 |
| 91 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.62239801 |
| 92 | cAMP catabolic process (GO:0006198) | 2.61436526 |
| 93 | cellular response to interleukin-15 (GO:0071350) | 2.61074400 |
| 94 | * glycosaminoglycan biosynthetic process (GO:0006024) | 2.60704983 |
| 95 | multicellular organismal catabolic process (GO:0044243) | 2.59964680 |
| 96 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.59544111 |
| 97 | wound healing, spreading of epidermal cells (GO:0035313) | 2.59534085 |
| 98 | mesodermal cell differentiation (GO:0048333) | 2.59373505 |
| 99 | cell migration involved in heart development (GO:0060973) | 2.59342038 |
| 100 | positive regulation of endothelial cell migration (GO:0010595) | 2.58474439 |
| 101 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.58432333 |
| 102 | endodermal cell differentiation (GO:0035987) | 2.58385881 |
| 103 | extracellular matrix disassembly (GO:0022617) | 2.58188172 |
| 104 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.57913701 |
| 105 | mature B cell differentiation (GO:0002335) | 2.57197981 |
| 106 | * aminoglycan biosynthetic process (GO:0006023) | 2.57018579 |
| 107 | adhesion of symbiont to host (GO:0044406) | 2.56557548 |
| 108 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.56514455 |
| 109 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.56018010 |
| 110 | * chondroitin sulfate metabolic process (GO:0030204) | 2.55902000 |
| 111 | cellular response to vitamin (GO:0071295) | 2.55538362 |
| 112 | cell adhesion mediated by integrin (GO:0033627) | 2.54378472 |
| 113 | activated T cell proliferation (GO:0050798) | 2.54029391 |
| 114 | regulation of extracellular matrix disassembly (GO:0010715) | 2.53855454 |
| 115 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.53808004 |
| 116 | tolerance induction (GO:0002507) | 2.52349377 |
| 117 | cyclic nucleotide catabolic process (GO:0009214) | 2.51541486 |
| 118 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.51033366 |
| 119 | sterol catabolic process (GO:0016127) | 2.50563122 |
| 120 | cholesterol catabolic process (GO:0006707) | 2.50563122 |
| 121 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.50463018 |
| 122 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.50347939 |
| 123 | extracellular matrix assembly (GO:0085029) | 2.49845504 |
| 124 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.49814105 |
| 125 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.49789132 |
| 126 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.49624620 |
| 127 | multicellular organismal metabolic process (GO:0044236) | 2.49211193 |
| 128 | smooth muscle tissue development (GO:0048745) | 2.48192726 |
| 129 | negative regulation of cartilage development (GO:0061037) | 2.48059077 |
| 130 | endothelium development (GO:0003158) | 2.47754047 |
| 131 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.46301638 |
| 132 | facial nerve structural organization (GO:0021612) | 2.45564958 |
| 133 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.45012103 |
| 134 | positive regulation of granulocyte differentiation (GO:0030854) | 2.44757953 |
| 135 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.44129462 |
| 136 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.43781538 |
| 137 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.43703321 |
| 138 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.42947542 |
| 139 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.39367182 |
| 140 | negative regulation of protein autophosphorylation (GO:0031953) | 2.39196156 |
| 141 | negative regulation of protein activation cascade (GO:2000258) | 2.39174601 |
| 142 | regulation of gamma-delta T cell activation (GO:0046643) | 2.38530318 |
| 143 | positive regulation of Rap GTPase activity (GO:0032854) | 2.38065106 |
| 144 | regulation of beta-amyloid formation (GO:1902003) | 2.37629347 |
| 145 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.37391529 |
| 146 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.35101175 |
| 147 | regulation of ARF protein signal transduction (GO:0032012) | 2.32319295 |
| 148 | microglial cell activation (GO:0001774) | 2.32053900 |
| 149 | leukocyte aggregation (GO:0070486) | 2.31032148 |
| 150 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.30432650 |
| 151 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.30351461 |
| 152 | establishment of endothelial barrier (GO:0061028) | 2.29947292 |
| 153 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.27907459 |
| 154 | thymic T cell selection (GO:0045061) | 2.27780477 |
| 155 | adaptation of signaling pathway (GO:0023058) | 2.26841734 |
| 156 | negative regulation of humoral immune response (GO:0002921) | 2.26303719 |
| 157 | inositol phosphate-mediated signaling (GO:0048016) | 2.24863924 |
| 158 | macrophage activation (GO:0042116) | 2.24415036 |
| 159 | regulation of memory T cell differentiation (GO:0043380) | 2.22953132 |
| 160 | regulation of germinal center formation (GO:0002634) | 2.18456774 |
| 161 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.16917207 |
| 162 | regulation of gonadotropin secretion (GO:0032276) | 2.16258008 |
| 163 | phospholipid dephosphorylation (GO:0046839) | 2.15065938 |
| 164 | growth hormone receptor signaling pathway (GO:0060396) | 2.15046043 |
| 165 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.14127350 |
| 166 | positive regulation of tolerance induction (GO:0002645) | 2.13787492 |
| 167 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.13346609 |
| 168 | T cell selection (GO:0045058) | 2.12242184 |
| 169 | regulation of T cell tolerance induction (GO:0002664) | 2.11812835 |
| 170 | germinal center formation (GO:0002467) | 2.10939972 |
| 171 | detection of molecule of bacterial origin (GO:0032490) | 2.09721027 |
| 172 | cellular response to growth hormone stimulus (GO:0071378) | 2.09232333 |
| 173 | regulation of actin filament-based movement (GO:1903115) | 2.08423578 |
| 174 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.07213223 |
| 175 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.07129288 |
| 176 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.05637082 |
| 177 | thyroid hormone metabolic process (GO:0042403) | 2.05631865 |
| 178 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.05191775 |
| 179 | negative regulation of B cell mediated immunity (GO:0002713) | 2.04038985 |
| 180 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.04038985 |
| 181 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.03263527 |
| 182 | thyroid hormone generation (GO:0006590) | 2.01789485 |
| 183 | positive regulation of gluconeogenesis (GO:0045722) | 2.01747717 |
| 184 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.00896969 |
| 185 | B cell receptor signaling pathway (GO:0050853) | 2.00373255 |
| 186 | protein targeting to Golgi (GO:0000042) | 2.00152101 |
| 187 | regulation of isotype switching to IgG isotypes (GO:0048302) | 1.99940052 |
| 188 | regulation of Rap GTPase activity (GO:0032317) | 1.99731440 |
| 189 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 1.99397198 |
| 190 | regulation of cell communication by electrical coupling (GO:0010649) | 1.98473751 |
| 191 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 1.97935389 |
| 192 | RNA destabilization (GO:0050779) | 1.96130056 |
| 193 | myelin maintenance (GO:0043217) | 1.95585254 |
| 194 | long-term synaptic potentiation (GO:0060291) | 1.94852616 |
| 195 | astrocyte differentiation (GO:0048708) | 1.94367063 |
| 196 | relaxation of cardiac muscle (GO:0055119) | 1.93853635 |
| 197 | response to monoamine (GO:0071867) | 1.93050499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.35057808 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.14629605 |
| 3 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.66302413 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.52652059 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.30172965 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.89897980 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.83664335 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.76174464 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.63118115 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.57499410 |
| 11 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.56479369 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49136584 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.41589579 |
| 14 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.41420767 |
| 15 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.40060453 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.36142017 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.34725174 |
| 18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.32091093 |
| 19 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.25553644 |
| 20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.16469950 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.16469950 |
| 22 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.16237969 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.13260869 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.06018305 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.98986012 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.93555927 |
| 27 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.91139049 |
| 28 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.89066469 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.88859265 |
| 30 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.88259665 |
| 31 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.83097960 |
| 32 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.82664054 |
| 33 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.82065452 |
| 34 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.77403903 |
| 35 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.77403903 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76533801 |
| 37 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.72550911 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.71864314 |
| 39 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.66237271 |
| 40 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.63457653 |
| 41 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.60808234 |
| 42 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.59361155 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.58363340 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.57985389 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.53946524 |
| 46 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.53180554 |
| 47 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.51744352 |
| 48 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.51052959 |
| 49 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.50345399 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.48671845 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.48361711 |
| 52 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.47542497 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47128723 |
| 54 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.46350085 |
| 55 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.46154331 |
| 56 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40118942 |
| 57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38176012 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37919255 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37813594 |
| 60 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36003708 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.34726576 |
| 62 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.33730018 |
| 63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.33708586 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33449284 |
| 65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.32589915 |
| 66 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.31488699 |
| 67 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.30951242 |
| 68 | TP53_16413492_ChIP-PET_HCT116_Human | 1.28771748 |
| 69 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.27838728 |
| 70 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.26769454 |
| 71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.24745849 |
| 72 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.24414116 |
| 73 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.24018533 |
| 74 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.23066541 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23060180 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.20962814 |
| 77 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20647941 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20545734 |
| 79 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20495335 |
| 80 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.17778188 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16721970 |
| 82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16283814 |
| 83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16166221 |
| 84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15006881 |
| 85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14434483 |
| 86 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.13870885 |
| 87 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13546765 |
| 88 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13350814 |
| 89 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10619246 |
| 90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09824383 |
| 91 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08824887 |
| 92 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08813336 |
| 93 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08530006 |
| 94 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07416186 |
| 95 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.05136055 |
| 96 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04827651 |
| 97 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04649203 |
| 98 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04622751 |
| 99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03607589 |
| 100 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02754953 |
| 101 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02739072 |
| 102 | MYB_26560356_Chip-Seq_TH2_Human | 1.02586920 |
| 103 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.01963428 |
| 104 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.01780327 |
| 105 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01387339 |
| 106 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99100660 |
| 107 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.98710040 |
| 108 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.97688207 |
| 109 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95987384 |
| 110 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.95386423 |
| 111 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95286934 |
| 112 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95133683 |
| 113 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.93982605 |
| 114 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93879133 |
| 115 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93879133 |
| 116 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93261747 |
| 117 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92370862 |
| 118 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91346959 |
| 119 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90945470 |
| 120 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90341315 |
| 121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89912115 |
| 122 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89828328 |
| 123 | FUS_26573619_Chip-Seq_HEK293_Human | 0.88937595 |
| 124 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87415694 |
| 125 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87319297 |
| 126 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.87291176 |
| 127 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.86980110 |
| 128 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.86977387 |
| 129 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86921034 |
| 130 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86869489 |
| 131 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86762315 |
| 132 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.86711751 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86555085 |
| 134 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.86191374 |
| 135 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85747674 |
| 136 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85687363 |
| 137 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84980415 |
| 138 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84789772 |
| 139 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84789772 |
| 140 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84760177 |
| 141 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83831204 |
| 142 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.83619930 |
| 143 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.83595914 |
| 144 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 0.82952772 |
| 145 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82910395 |
| 146 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82417791 |
| 147 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82274357 |
| 148 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81881085 |
| 149 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.81815954 |
| 150 | AR_25329375_ChIP-Seq_VCAP_Human | 0.81215614 |
| 151 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80222541 |
| 152 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.80172863 |
| 153 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79821619 |
| 154 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79723480 |
| 155 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.78923746 |
| 156 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.78629320 |
| 157 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78532090 |
| 158 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.78018231 |
| 159 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.77580026 |
| 160 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.77391330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 6.58429160 |
| 2 | MP0005503_abnormal_tendon_morphology | 5.10170984 |
| 3 | MP0003279_aneurysm | 4.98762872 |
| 4 | MP0001958_emphysema | 4.36322558 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 4.09391421 |
| 6 | MP0005275_abnormal_skin_tensile | 4.00591464 |
| 7 | MP0009384_cardiac_valve_regurgitation | 3.97944006 |
| 8 | MP0006054_spinal_hemorrhage | 2.98808130 |
| 9 | MP0010368_abnormal_lymphatic_system | 2.60276598 |
| 10 | MP0002166_altered_tumor_susceptibility | 2.58029880 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.51386351 |
| 12 | MP0001986_abnormal_taste_sensitivity | 2.39847480 |
| 13 | MP0005623_abnormal_meninges_morphology | 2.32236612 |
| 14 | MP0001879_abnormal_lymphatic_vessel | 2.29523322 |
| 15 | MP0003436_decreased_susceptibility_to | 2.26693751 |
| 16 | MP0004272_abnormal_basement_membrane | 2.22333683 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.16393579 |
| 18 | MP0002282_abnormal_trachea_morphology | 2.01340846 |
| 19 | MP0000685_abnormal_immune_system | 1.97959536 |
| 20 | MP0003763_abnormal_thymus_physiology | 1.97168169 |
| 21 | MP0002009_preneoplasia | 1.97064815 |
| 22 | MP0005508_abnormal_skeleton_morphology | 1.96355250 |
| 23 | MP0002933_joint_inflammation | 1.96035753 |
| 24 | MP0004134_abnormal_chest_morphology | 1.93909130 |
| 25 | MP0003941_abnormal_skin_development | 1.93815503 |
| 26 | MP0003303_peritoneal_inflammation | 1.86493652 |
| 27 | MP0009250_abnormal_appendicular_skeleto | 1.84936698 |
| 28 | MP0005171_absent_coat_pigmentation | 1.80617533 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 1.72360489 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.71040238 |
| 31 | MP0002295_abnormal_pulmonary_circulatio | 1.67609115 |
| 32 | MP0003724_increased_susceptibility_to | 1.65901870 |
| 33 | MP0002006_tumorigenesis | 1.65645841 |
| 34 | MP0002060_abnormal_skin_morphology | 1.59794118 |
| 35 | MP0001800_abnormal_humoral_immune | 1.55075845 |
| 36 | MP0005671_abnormal_response_to | 1.53377596 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.52810275 |
| 38 | MP0001542_abnormal_bone_strength | 1.51436198 |
| 39 | MP0009785_altered_susceptibility_to | 1.50616438 |
| 40 | MP0009379_abnormal_foot_pigmentation | 1.49973274 |
| 41 | MP0002419_abnormal_innate_immunity | 1.48554569 |
| 42 | MP0000767_abnormal_smooth_muscle | 1.48519313 |
| 43 | MP0001299_abnormal_eye_distance/ | 1.44499628 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.41095954 |
| 45 | MP0004147_increased_porphyrin_level | 1.40535017 |
| 46 | MP0005387_immune_system_phenotype | 1.38875838 |
| 47 | MP0001790_abnormal_immune_system | 1.38875838 |
| 48 | MP0002089_abnormal_postnatal_growth/wei | 1.38123325 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.37900356 |
| 50 | MP0003690_abnormal_glial_cell | 1.36324422 |
| 51 | MP0005595_abnormal_vascular_smooth | 1.35764178 |
| 52 | MP0000569_abnormal_digit_pigmentation | 1.35428569 |
| 53 | MP0002249_abnormal_larynx_morphology | 1.35046937 |
| 54 | MP0004130_abnormal_muscle_cell | 1.34852126 |
| 55 | MP0005390_skeleton_phenotype | 1.34638657 |
| 56 | * MP0000163_abnormal_cartilage_morphology | 1.33432798 |
| 57 | MP0001188_hyperpigmentation | 1.33414348 |
| 58 | MP0009278_abnormal_bone_marrow | 1.32628147 |
| 59 | MP0008004_abnormal_stomach_pH | 1.31034181 |
| 60 | MP0002723_abnormal_immune_serum | 1.30487502 |
| 61 | MP0002108_abnormal_muscle_morphology | 1.30446021 |
| 62 | MP0002896_abnormal_bone_mineralization | 1.28563338 |
| 63 | MP0005023_abnormal_wound_healing | 1.27738271 |
| 64 | MP0003091_abnormal_cell_migration | 1.23939910 |
| 65 | MP0000762_abnormal_tongue_morphology | 1.23816048 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.22372358 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.22239560 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.21337569 |
| 69 | MP0009745_abnormal_behavioral_response | 1.21262026 |
| 70 | MP0003633_abnormal_nervous_system | 1.20789366 |
| 71 | * MP0002115_abnormal_skeleton_extremities | 1.20073909 |
| 72 | MP0002420_abnormal_adaptive_immunity | 1.19591982 |
| 73 | MP0001819_abnormal_immune_cell | 1.17028038 |
| 74 | MP0010155_abnormal_intestine_physiology | 1.16485858 |
| 75 | MP0005025_abnormal_response_to | 1.15845700 |
| 76 | MP0004947_skin_inflammation | 1.13630307 |
| 77 | MP0003283_abnormal_digestive_organ | 1.13123152 |
| 78 | MP0000343_altered_response_to | 1.12913403 |
| 79 | MP0002909_abnormal_adrenal_gland | 1.12506631 |
| 80 | MP0002452_abnormal_antigen_presenting | 1.12004148 |
| 81 | MP0004859_abnormal_synaptic_plasticity | 1.10196627 |
| 82 | MP0005165_increased_susceptibility_to | 1.08845062 |
| 83 | MP0003385_abnormal_body_wall | 1.08659999 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 1.08238106 |
| 85 | * MP0002113_abnormal_skeleton_development | 1.06733998 |
| 86 | MP0001533_abnormal_skeleton_physiology | 1.06665994 |
| 87 | MP0009780_abnormal_chondrocyte_physiolo | 1.06654427 |
| 88 | MP0002932_abnormal_joint_morphology | 1.05696659 |
| 89 | MP0002064_seizures | 1.04166244 |
| 90 | MP0002128_abnormal_blood_circulation | 1.03935299 |
| 91 | MP0004381_abnormal_hair_follicle | 1.03415557 |
| 92 | MP0002148_abnormal_hypersensitivity_rea | 1.02676753 |
| 93 | MP0006138_congestive_heart_failure | 1.00644102 |
| 94 | MP0001270_distended_abdomen | 0.99762457 |
| 95 | MP0002168_other_aberrant_phenotype | 0.99188943 |
| 96 | MP0003195_calcinosis | 0.98155162 |
| 97 | MP0002693_abnormal_pancreas_physiology | 0.96950938 |
| 98 | MP0005310_abnormal_salivary_gland | 0.96546777 |
| 99 | MP0002405_respiratory_system_inflammati | 0.96038193 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.95302492 |
| 101 | MP0000920_abnormal_myelination | 0.94703507 |
| 102 | MP0004883_abnormal_blood_vessel | 0.94295583 |
| 103 | MP0000013_abnormal_adipose_tissue | 0.92406645 |
| 104 | MP0005166_decreased_susceptibility_to | 0.92283692 |
| 105 | MP0001486_abnormal_startle_reflex | 0.91861649 |
| 106 | MP0000751_myopathy | 0.91410877 |
| 107 | MP0005164_abnormal_response_to | 0.91019157 |
| 108 | MP0001756_abnormal_urination | 0.90628120 |
| 109 | MP0001243_abnormal_dermal_layer | 0.89959236 |
| 110 | MP0002138_abnormal_hepatobiliary_system | 0.88859723 |
| 111 | MP0002133_abnormal_respiratory_system | 0.87594197 |
| 112 | MP0005388_respiratory_system_phenotype | 0.87594197 |
| 113 | MP0003329_amyloid_beta_deposits | 0.86653021 |
| 114 | MP0001502_abnormal_circadian_rhythm | 0.85037770 |
| 115 | MP0005257_abnormal_intraocular_pressure | 0.84631329 |
| 116 | MP0002736_abnormal_nociception_after | 0.84537172 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.84378909 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.84359226 |
| 119 | MP0000049_abnormal_middle_ear | 0.83996060 |
| 120 | MP0004510_myositis | 0.83799486 |
| 121 | MP0003631_nervous_system_phenotype | 0.83657807 |
| 122 | MP0003880_abnormal_central_pattern | 0.83361484 |
| 123 | MP0010030_abnormal_orbit_morphology | 0.83257912 |
| 124 | MP0003866_abnormal_defecation | 0.82407027 |
| 125 | MP0001853_heart_inflammation | 0.81673967 |
| 126 | MP0004885_abnormal_endolymph | 0.81264080 |
| 127 | MP0000716_abnormal_immune_system | 0.79835173 |
| 128 | MP0004270_analgesia | 0.79289057 |
| 129 | MP0003075_altered_response_to | 0.78594677 |
| 130 | MP0003191_abnormal_cellular_cholesterol | 0.77855480 |
| 131 | MP0001845_abnormal_inflammatory_respons | 0.77446145 |
| 132 | MP0002638_abnormal_pupillary_reflex | 0.77042189 |
| 133 | MP0004215_abnormal_myocardial_fiber | 0.77017055 |
| 134 | MP0002254_reproductive_system_inflammat | 0.76526436 |
| 135 | MP0002398_abnormal_bone_marrow | 0.76430870 |
| 136 | MP0008775_abnormal_heart_ventricle | 0.75767748 |
| 137 | MP0003795_abnormal_bone_structure | 0.75629851 |
| 138 | MP0000230_abnormal_systemic_arterial | 0.75357065 |
| 139 | MP0003828_pulmonary_edema | 0.75310623 |
| 140 | MP0003635_abnormal_synaptic_transmissio | 0.74705134 |
| 141 | MP0002272_abnormal_nervous_system | 0.73604554 |
| 142 | MP0001545_abnormal_hematopoietic_system | 0.72303223 |
| 143 | MP0005397_hematopoietic_system_phenotyp | 0.72303223 |
| 144 | MP0003943_abnormal_hepatobiliary_system | 0.72066069 |
| 145 | MP0000681_abnormal_thyroid_gland | 0.69799277 |
| 146 | MP0001614_abnormal_blood_vessel | 0.69483286 |
| 147 | * MP0002109_abnormal_limb_morphology | 0.69091648 |
| 148 | MP0000749_muscle_degeneration | 0.68579051 |
| 149 | MP0004858_abnormal_nervous_system | 0.66974825 |
| 150 | MP0005167_abnormal_blood-brain_barrier | 0.66681838 |
| 151 | * MP0002114_abnormal_axial_skeleton | 0.65501271 |
| 152 | MP0000249_abnormal_blood_vessel | 0.64936100 |
| 153 | MP0004484_altered_response_of | 0.63980384 |
| 154 | MP0001851_eye_inflammation | 0.63722406 |
| 155 | MP0005464_abnormal_platelet_physiology | 0.62723789 |
| 156 | MP0003942_abnormal_urinary_system | 0.62574565 |
| 157 | MP0004084_abnormal_cardiac_muscle | 0.58889286 |
| 158 | MP0010771_integument_phenotype | 0.56168137 |
| 159 | MP0002116_abnormal_craniofacial_bone | 0.56089698 |
| 160 | MP0000432_abnormal_head_morphology | 0.52695994 |
| 161 | MP0004036_abnormal_muscle_relaxation | 0.52635561 |
| 162 | MP0000516_abnormal_urinary_system | 0.51361189 |
| 163 | MP0005367_renal/urinary_system_phenotyp | 0.51361189 |
| 164 | MP0008874_decreased_physiological_sensi | 0.49216551 |
| 165 | MP0002396_abnormal_hematopoietic_system | 0.48639045 |
| 166 | MP0001175_abnormal_lung_morphology | 0.47439768 |
| 167 | MP0003045_fibrosis | 0.46520608 |
| 168 | MP0001177_atelectasis | 0.46339378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 6.87223257 |
| 2 | Beaking of vertebral bodies (HP:0004568) | 5.77921415 |
| 3 | Premature rupture of membranes (HP:0001788) | 5.39154690 |
| 4 | Patchy hypopigmentation of hair (HP:0011365) | 5.00155754 |
| 5 | Neonatal short-limb short stature (HP:0008921) | 4.79898864 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 4.64148477 |
| 7 | T lymphocytopenia (HP:0005403) | 4.40875762 |
| 8 | Thyroiditis (HP:0100646) | 4.37282241 |
| 9 | Severe combined immunodeficiency (HP:0004430) | 4.26380164 |
| 10 | Hypoplasia of the thymus (HP:0000778) | 4.21204604 |
| 11 | Spinal rigidity (HP:0003306) | 4.20418887 |
| 12 | B lymphocytopenia (HP:0010976) | 4.18046482 |
| 13 | Abnormality of B cell number (HP:0010975) | 4.10232064 |
| 14 | Aortic aneurysm (HP:0004942) | 4.09238471 |
| 15 | Aortic dissection (HP:0002647) | 4.02945493 |
| 16 | Abnormality of T cell number (HP:0011839) | 4.01951729 |
| 17 | Biconcave vertebral bodies (HP:0004586) | 3.68842113 |
| 18 | Soft skin (HP:0000977) | 3.68483863 |
| 19 | Hypoproteinemia (HP:0003075) | 3.68466116 |
| 20 | Eosinophilia (HP:0001880) | 3.63800286 |
| 21 | Stomatitis (HP:0010280) | 3.62220922 |
| 22 | Vertebral compression fractures (HP:0002953) | 3.59451195 |
| 23 | Eczematoid dermatitis (HP:0000976) | 3.57703982 |
| 24 | Vascular tortuosity (HP:0004948) | 3.48143028 |
| 25 | Generalized amyotrophy (HP:0003700) | 3.41844467 |
| 26 | Overlapping toe (HP:0001845) | 3.40761535 |
| 27 | Epiphyseal dysplasia (HP:0002656) | 3.40081866 |
| 28 | Large for gestational age (HP:0001520) | 3.37265386 |
| 29 | Recurrent fungal infections (HP:0002841) | 3.34982851 |
| 30 | Arterial tortuosity (HP:0005116) | 3.30108294 |
| 31 | Abnormality of dentin (HP:0010299) | 3.29289319 |
| 32 | Peritonitis (HP:0002586) | 3.28310955 |
| 33 | Atrophic scars (HP:0001075) | 3.20103412 |
| 34 | Follicular hyperkeratosis (HP:0007502) | 3.11131734 |
| 35 | Granulocytopenia (HP:0001913) | 3.10448972 |
| 36 | Rib fusion (HP:0000902) | 3.10230467 |
| 37 | Cervical subluxation (HP:0003308) | 3.06025599 |
| 38 | Overgrowth (HP:0001548) | 3.04454119 |
| 39 | Myositis (HP:0100614) | 3.03045228 |
| 40 | Broad metatarsal (HP:0001783) | 3.02639439 |
| 41 | Dilatation of the ascending aorta (HP:0005111) | 3.00848966 |
| 42 | Abnormality of eosinophils (HP:0001879) | 3.00171456 |
| 43 | Bladder diverticulum (HP:0000015) | 2.99685941 |
| 44 | Increased CSF protein (HP:0002922) | 2.92627043 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.91161158 |
| 46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.89951818 |
| 47 | Wormian bones (HP:0002645) | 2.89468455 |
| 48 | Hemiplegia (HP:0002301) | 2.89013719 |
| 49 | Joint stiffness (HP:0001387) | 2.88023926 |
| 50 | Fragile skin (HP:0001030) | 2.87222355 |
| 51 | Abnormality of macular pigmentation (HP:0008002) | 2.85904781 |
| 52 | Papilledema (HP:0001085) | 2.85678205 |
| 53 | Cupped ribs (HP:0000887) | 2.84743579 |
| 54 | Abnormality of skull ossification (HP:0002703) | 2.84654193 |
| 55 | Decreased skull ossification (HP:0004331) | 2.84151460 |
| 56 | Abnormality of the lumbar spine (HP:0100712) | 2.82330139 |
| 57 | Hematochezia (HP:0002573) | 2.80104439 |
| 58 | Abnormality of T cells (HP:0002843) | 2.79642377 |
| 59 | Combined immunodeficiency (HP:0005387) | 2.77017481 |
| 60 | Radial bowing (HP:0002986) | 2.73540277 |
| 61 | Orchitis (HP:0100796) | 2.69911892 |
| 62 | Ankle contracture (HP:0006466) | 2.69348872 |
| 63 | Episodic fever (HP:0001954) | 2.65150949 |
| 64 | Agammaglobulinemia (HP:0004432) | 2.63959314 |
| 65 | Retrobulbar optic neuritis (HP:0100654) | 2.62015374 |
| 66 | Optic neuritis (HP:0100653) | 2.62015374 |
| 67 | Coxa vara (HP:0002812) | 2.60441159 |
| 68 | Leukocytosis (HP:0001974) | 2.56695331 |
| 69 | Ectopia lentis (HP:0001083) | 2.56149153 |
| 70 | Supernumerary nipples (HP:0002558) | 2.56031202 |
| 71 | Flat face (HP:0012368) | 2.55664882 |
| 72 | Meningitis (HP:0001287) | 2.53198112 |
| 73 | Stomach cancer (HP:0012126) | 2.44969675 |
| 74 | Absent frontal sinuses (HP:0002688) | 2.44422020 |
| 75 | Coarse hair (HP:0002208) | 2.44253087 |
| 76 | Bowel diverticulosis (HP:0005222) | 2.42888334 |
| 77 | Verrucae (HP:0200043) | 2.42853016 |
| 78 | Papilloma (HP:0012740) | 2.42853016 |
| 79 | Wide nose (HP:0000445) | 2.42048631 |
| 80 | Flat capital femoral epiphysis (HP:0003370) | 2.38160845 |
| 81 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.37108440 |
| 82 | Shawl scrotum (HP:0000049) | 2.36709967 |
| 83 | Irregular epiphyses (HP:0010582) | 2.36093275 |
| 84 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.35774213 |
| 85 | Osteoarthritis (HP:0002758) | 2.35184719 |
| 86 | Infantile muscular hypotonia (HP:0008947) | 2.33587980 |
| 87 | Mild short stature (HP:0003502) | 2.32316200 |
| 88 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.32105988 |
| 89 | Blue sclerae (HP:0000592) | 2.31428812 |
| 90 | Shallow orbits (HP:0000586) | 2.30516040 |
| 91 | Ovoid vertebral bodies (HP:0003300) | 2.28347726 |
| 92 | IgG deficiency (HP:0004315) | 2.27620053 |
| 93 | Bundle branch block (HP:0011710) | 2.26059921 |
| 94 | Hemiparesis (HP:0001269) | 2.25389438 |
| 95 | Congenital sensorineural hearing impairment (HP:0008527) | 2.25300414 |
| 96 | Craniofacial hyperostosis (HP:0004493) | 2.24496880 |
| 97 | Recurrent viral infections (HP:0004429) | 2.23730365 |
| 98 | Action tremor (HP:0002345) | 2.22580235 |
| 99 | Testicular neoplasm (HP:0010788) | 2.21920484 |
| 100 | Abnormality of the acetabulum (HP:0003170) | 2.21279343 |
| 101 | Ventricular fibrillation (HP:0001663) | 2.19362379 |
| 102 | Aortic valve stenosis (HP:0001650) | 2.19029259 |
| 103 | Growth hormone excess (HP:0000845) | 2.18442341 |
| 104 | Increased IgE level (HP:0003212) | 2.18406222 |
| 105 | Syncope (HP:0001279) | 2.18038997 |
| 106 | Abnormality of binocular vision (HP:0011514) | 2.16683396 |
| 107 | Diplopia (HP:0000651) | 2.16683396 |
| 108 | Febrile seizures (HP:0002373) | 2.16385839 |
| 109 | Abnormal delivery (HP:0001787) | 2.15273461 |
| 110 | Striae distensae (HP:0001065) | 2.13728951 |
| 111 | Recurrent bronchitis (HP:0002837) | 2.13543154 |
| 112 | Sepsis (HP:0100806) | 2.13276675 |
| 113 | Atrial fibrillation (HP:0005110) | 2.13039503 |
| 114 | Abnormality of primary teeth (HP:0006481) | 2.10467433 |
| 115 | Pulmonary infiltrates (HP:0002113) | 2.09530199 |
| 116 | Genu recurvatum (HP:0002816) | 2.08336882 |
| 117 | Asymmetry of the thorax (HP:0001555) | 2.06922850 |
| 118 | Nasal speech (HP:0001611) | 2.06759480 |
| 119 | Enlarged penis (HP:0000040) | 2.06323343 |
| 120 | Self-mutilation (HP:0000742) | 2.03549666 |
| 121 | Osteomyelitis (HP:0002754) | 2.02641880 |
| 122 | Small epiphyses (HP:0010585) | 2.01701875 |
| 123 | Sprengel anomaly (HP:0000912) | 1.99843371 |
| 124 | Abnormal tarsal ossification (HP:0008369) | 1.98575227 |
| 125 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.97393343 |
| 126 | Gastrointestinal infarctions (HP:0005244) | 1.97377570 |
| 127 | Abnormality of the frontal sinuses (HP:0002687) | 1.97301774 |
| 128 | Vitreoretinal degeneration (HP:0000655) | 1.96982704 |
| 129 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94511762 |
| 130 | Pustule (HP:0200039) | 1.94016779 |
| 131 | Cellulitis (HP:0100658) | 1.93836366 |
| 132 | Thin bony cortex (HP:0002753) | 1.93751052 |
| 133 | Hyperextensible skin (HP:0000974) | 1.93714520 |
| 134 | Short nail (HP:0001799) | 1.93304042 |
| 135 | Hyporeflexia of lower limbs (HP:0002600) | 1.93163041 |
| 136 | Spinal cord lesions (HP:0100561) | 1.93118767 |
| 137 | Syringomyelia (HP:0003396) | 1.93118767 |
| 138 | Spinal cord compression (HP:0002176) | 1.92545075 |
| 139 | Aplasia involving bones of the extremities (HP:0009825) | 1.92530051 |
| 140 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.92530051 |
| 141 | Aplasia of the phalanges of the hand (HP:0009802) | 1.92530051 |
| 142 | Fatigue (HP:0012378) | 1.92424950 |
| 143 | Keratoconjunctivitis (HP:0001096) | 1.91361451 |
| 144 | Mitral regurgitation (HP:0001653) | 1.91000756 |
| 145 | Generalized hypopigmentation of hair (HP:0011358) | 1.90988461 |
| 146 | Spondylolisthesis (HP:0003302) | 1.90958925 |
| 147 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.89972307 |
| 148 | Abnormality of the axillary hair (HP:0100134) | 1.89626765 |
| 149 | Abnormality of secondary sexual hair (HP:0009888) | 1.89626765 |
| 150 | Recurrent abscess formation (HP:0002722) | 1.89557869 |
| 151 | Inguinal hernia (HP:0000023) | 1.89376393 |
| 152 | Prolonged bleeding time (HP:0003010) | 1.88910341 |
| 153 | Primary atrial arrhythmia (HP:0001692) | 1.88341825 |
| 154 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.87701903 |
| 155 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.87302343 |
| 156 | Gaze-evoked nystagmus (HP:0000640) | 1.87115558 |
| 157 | Mesomelia (HP:0003027) | 1.86607009 |
| 158 | Cranial hyperostosis (HP:0004437) | 1.85923223 |
| 159 | Subacute progressive viral hepatitis (HP:0006572) | 1.85613542 |
| 160 | Hypoplastic ischia (HP:0003175) | 1.85353749 |
| 161 | Sparse eyelashes (HP:0000653) | 1.85024466 |
| 162 | Widely spaced teeth (HP:0000687) | 1.84664618 |
| 163 | Amyloidosis (HP:0011034) | 1.84196582 |
| 164 | Abnormal number of erythroid precursors (HP:0012131) | 1.84135299 |
| 165 | Hypothermia (HP:0002045) | 1.83139175 |
| 166 | Mitral valve prolapse (HP:0001634) | 1.81207841 |
| 167 | Bowing of the arm (HP:0006488) | 1.81187425 |
| 168 | Bowed forearm bones (HP:0003956) | 1.81187425 |
| 169 | Lumbar hyperlordosis (HP:0002938) | 1.80163986 |
| 170 | Blue irides (HP:0000635) | 1.79997522 |
| 171 | Hyperlipoproteinemia (HP:0010980) | 1.79190661 |
| 172 | Mitral stenosis (HP:0001718) | 1.79097125 |
| 173 | Keratoconjunctivitis sicca (HP:0001097) | 1.77615811 |
| 174 | Abnormality of T cell physiology (HP:0011840) | 1.77389128 |
| 175 | Abnormality of the 2nd finger (HP:0004100) | 1.77027513 |
| 176 | Spinal canal stenosis (HP:0003416) | 1.76501680 |
| 177 | Hemoptysis (HP:0002105) | 1.76489763 |
| 178 | Joint swelling (HP:0001386) | 1.75317207 |
| 179 | Progressive cerebellar ataxia (HP:0002073) | 1.75298019 |
| 180 | Bradycardia (HP:0001662) | 1.74679842 |
| 181 | Global brain atrophy (HP:0002283) | 1.74093578 |
| 182 | Abnormality of macrophages (HP:0004311) | 1.74032413 |
| 183 | Supraventricular arrhythmia (HP:0005115) | 1.73623843 |
| 184 | Abnormal EKG (HP:0003115) | 1.73563169 |
| 185 | Ventricular arrhythmia (HP:0004308) | 1.72837306 |
| 186 | Cerebral aneurysm (HP:0004944) | 1.72753539 |
| 187 | Mediastinal lymphadenopathy (HP:0100721) | 1.72638221 |
| 188 | Gingival bleeding (HP:0000225) | 1.72359100 |
| 189 | Supraventricular tachycardia (HP:0004755) | 1.72207010 |
| 190 | Obstructive sleep apnea (HP:0002870) | 1.71595063 |
| 191 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.71437398 |
| 192 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.71437398 |
| 193 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71437398 |
| 194 | Prolonged QT interval (HP:0001657) | 1.71186470 |
| 195 | Heart block (HP:0012722) | 1.70351812 |
| 196 | Hypokalemic alkalosis (HP:0001949) | 1.69856296 |
| 197 | Fair hair (HP:0002286) | 1.68977708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.76512365 |
| 2 | MAP2K3 | 3.72759472 |
| 3 | MUSK | 3.72227054 |
| 4 | TIE1 | 3.58372245 |
| 5 | EEF2K | 3.44142987 |
| 6 | PKN2 | 3.37942738 |
| 7 | TNIK | 3.33098844 |
| 8 | INSRR | 3.06074041 |
| 9 | DDR2 | 2.83654396 |
| 10 | MAP3K3 | 2.83579701 |
| 11 | FRK | 2.55324492 |
| 12 | MAPKAPK5 | 2.53675093 |
| 13 | TAOK3 | 2.31551786 |
| 14 | MAP2K6 | 2.24341199 |
| 15 | FGFR3 | 2.21169172 |
| 16 | MAPKAPK3 | 2.06044711 |
| 17 | VRK1 | 1.98397312 |
| 18 | MAP4K1 | 1.93538589 |
| 19 | RIPK4 | 1.85886164 |
| 20 | TGFBR2 | 1.85494809 |
| 21 | NLK | 1.83348764 |
| 22 | TRPM7 | 1.79489044 |
| 23 | NTRK3 | 1.78377491 |
| 24 | STK38 | 1.74440806 |
| 25 | ZAP70 | 1.66840320 |
| 26 | PIM2 | 1.65793700 |
| 27 | MYLK | 1.65391581 |
| 28 | JAK1 | 1.64383531 |
| 29 | TGFBR1 | 1.62573158 |
| 30 | RPS6KA4 | 1.59987934 |
| 31 | LATS2 | 1.59709628 |
| 32 | MAP3K13 | 1.57156205 |
| 33 | KDR | 1.56716092 |
| 34 | TXK | 1.55641273 |
| 35 | EPHB1 | 1.53757064 |
| 36 | PRPF4B | 1.42712596 |
| 37 | PRKG2 | 1.42693398 |
| 38 | ITK | 1.38302416 |
| 39 | CASK | 1.34651100 |
| 40 | MKNK1 | 1.31831535 |
| 41 | EPHA3 | 1.31137734 |
| 42 | PAK3 | 1.28646203 |
| 43 | TYK2 | 1.26440046 |
| 44 | MAPK12 | 1.25530191 |
| 45 | GRK6 | 1.22659080 |
| 46 | SIK1 | 1.21135806 |
| 47 | LRRK2 | 1.21015110 |
| 48 | MAPK13 | 1.15898112 |
| 49 | MAP3K7 | 1.13907716 |
| 50 | ERBB3 | 1.11904505 |
| 51 | MAP3K12 | 1.11579155 |
| 52 | CSK | 1.10817785 |
| 53 | FES | 1.07986113 |
| 54 | CAMKK2 | 1.07339979 |
| 55 | EIF2AK3 | 1.03068170 |
| 56 | MAP3K14 | 1.02381335 |
| 57 | STK24 | 1.00932790 |
| 58 | ILK | 1.00838703 |
| 59 | MKNK2 | 0.98987562 |
| 60 | CAMKK1 | 0.98533767 |
| 61 | RPS6KB2 | 0.96800859 |
| 62 | ERN1 | 0.96790061 |
| 63 | KIT | 0.96134067 |
| 64 | DAPK2 | 0.95813822 |
| 65 | SYK | 0.93746301 |
| 66 | NEK6 | 0.93621300 |
| 67 | MARK2 | 0.93297261 |
| 68 | PRKD3 | 0.93125448 |
| 69 | IRAK1 | 0.92821509 |
| 70 | BMPR1B | 0.92600118 |
| 71 | IKBKE | 0.91380429 |
| 72 | FGFR2 | 0.91141402 |
| 73 | STK11 | 0.89236710 |
| 74 | MAP2K2 | 0.89057544 |
| 75 | HCK | 0.88219999 |
| 76 | PTK2B | 0.87516639 |
| 77 | MAP3K1 | 0.86973924 |
| 78 | PTK6 | 0.86708689 |
| 79 | SIK3 | 0.85174107 |
| 80 | BLK | 0.84336727 |
| 81 | BMPR2 | 0.82911735 |
| 82 | GRK5 | 0.82595640 |
| 83 | CAMK4 | 0.82337950 |
| 84 | LCK | 0.78915915 |
| 85 | CAMK1 | 0.78586304 |
| 86 | FGFR1 | 0.78310179 |
| 87 | RAF1 | 0.75786634 |
| 88 | CDC42BPA | 0.74512529 |
| 89 | PAK2 | 0.73749462 |
| 90 | PINK1 | 0.73734882 |
| 91 | UHMK1 | 0.72525153 |
| 92 | YES1 | 0.71869916 |
| 93 | SGK2 | 0.71842734 |
| 94 | IRAK4 | 0.71764512 |
| 95 | PDGFRA | 0.71419717 |
| 96 | MAP2K7 | 0.70655528 |
| 97 | JAK2 | 0.70179440 |
| 98 | BTK | 0.69762395 |
| 99 | NTRK2 | 0.69505779 |
| 100 | PIK3CA | 0.69408434 |
| 101 | NME1 | 0.67841624 |
| 102 | MAP3K2 | 0.66984115 |
| 103 | CDK19 | 0.65809514 |
| 104 | STK16 | 0.65649952 |
| 105 | FGFR4 | 0.65365386 |
| 106 | STK4 | 0.64579973 |
| 107 | PRKAA2 | 0.64329316 |
| 108 | LYN | 0.64296552 |
| 109 | WNK1 | 0.64261415 |
| 110 | SGK494 | 0.63345158 |
| 111 | SGK223 | 0.63345158 |
| 112 | HIPK2 | 0.63281942 |
| 113 | MAPK7 | 0.62491822 |
| 114 | MOS | 0.61640075 |
| 115 | STK39 | 0.61273247 |
| 116 | NME2 | 0.60947483 |
| 117 | NTRK1 | 0.60221454 |
| 118 | FER | 0.59113261 |
| 119 | PDK1 | 0.58794944 |
| 120 | MAPK11 | 0.57366133 |
| 121 | LMTK2 | 0.56801823 |
| 122 | RET | 0.56599998 |
| 123 | DMPK | 0.56415459 |
| 124 | PRKD2 | 0.55386723 |
| 125 | TBK1 | 0.54136824 |
| 126 | TTN | 0.53726472 |
| 127 | EIF2AK1 | 0.50632826 |
| 128 | RIPK1 | 0.50407458 |
| 129 | MATK | 0.49284504 |
| 130 | MET | 0.48732096 |
| 131 | PHKG1 | 0.48309238 |
| 132 | PHKG2 | 0.48309238 |
| 133 | MAPK4 | 0.48225164 |
| 134 | MAP2K1 | 0.47283004 |
| 135 | ADRBK1 | 0.46990570 |
| 136 | IKBKB | 0.46873376 |
| 137 | GRK1 | 0.46760231 |
| 138 | TEC | 0.45811654 |
| 139 | PAK4 | 0.45315187 |
| 140 | PRKCH | 0.45252619 |
| 141 | PIK3CG | 0.43139377 |
| 142 | CSF1R | 0.41501015 |
| 143 | ROCK1 | 0.40820425 |
| 144 | JAK3 | 0.38616717 |
| 145 | PRKD1 | 0.38043273 |
| 146 | PRKCE | 0.37899170 |
| 147 | NUAK1 | 0.37784998 |
| 148 | MAP3K6 | 0.37109406 |
| 149 | EPHA4 | 0.35864809 |
| 150 | MINK1 | 0.35831992 |
| 151 | IGF1R | 0.34772255 |
| 152 | PDPK1 | 0.32235121 |
| 153 | PDGFRB | 0.28192982 |
| 154 | MAPKAPK2 | 0.27811817 |
| 155 | TNK2 | 0.27162275 |
| 156 | EIF2AK2 | 0.26628584 |
| 157 | SGK3 | 0.26380764 |
| 158 | SRC | 0.26363643 |
| 159 | RPS6KB1 | 0.26360528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 4.27705320 |
| 2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.49176950 |
| 3 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.88755542 |
| 4 | Malaria_Homo sapiens_hsa05144 | 2.74452653 |
| 5 | Platelet activation_Homo sapiens_hsa04611 | 2.44519023 |
| 6 | Focal adhesion_Homo sapiens_hsa04510 | 2.07795615 |
| 7 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.05233892 |
| 8 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.92244604 |
| 9 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.88805494 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.88528908 |
| 11 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.66788045 |
| 12 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.59180161 |
| 13 | Circadian rhythm_Homo sapiens_hsa04710 | 1.56332551 |
| 14 | Shigellosis_Homo sapiens_hsa05131 | 1.51285325 |
| 15 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46132832 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.43606771 |
| 17 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.43506446 |
| 18 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.40913710 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38129974 |
| 20 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.32752857 |
| 21 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.31806321 |
| 22 | Circadian entrainment_Homo sapiens_hsa04713 | 1.30465222 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.29765958 |
| 24 | Morphine addiction_Homo sapiens_hsa05032 | 1.29698195 |
| 25 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.28041030 |
| 26 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.27587689 |
| 27 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.26568365 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.26346023 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.22955379 |
| 30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.22663900 |
| 31 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.18139077 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.17941805 |
| 33 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.17346175 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.16172269 |
| 35 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.15385522 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.14976259 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.13710618 |
| 38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.13514672 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.12061468 |
| 40 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.11233695 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 1.10748130 |
| 42 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.09651386 |
| 43 | Long-term depression_Homo sapiens_hsa04730 | 1.09260434 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.08804161 |
| 45 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.08094023 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07651077 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.07438373 |
| 48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.07175752 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06003410 |
| 50 | Long-term potentiation_Homo sapiens_hsa04720 | 1.04734343 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 1.03131005 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02803097 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02433415 |
| 54 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.01463721 |
| 55 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.01036457 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99866920 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99459322 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98498998 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95936292 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94694132 |
| 61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.94369059 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.94139189 |
| 63 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.92384078 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92127587 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91377880 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.90627470 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88014315 |
| 68 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.87885837 |
| 69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86713645 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.86671151 |
| 71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85934237 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85429799 |
| 73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85182518 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 0.83307879 |
| 75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83081063 |
| 76 | Leishmaniasis_Homo sapiens_hsa05140 | 0.81499471 |
| 77 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81389194 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.81381720 |
| 79 | Allograft rejection_Homo sapiens_hsa05330 | 0.80652181 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.80244527 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.79844980 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79431677 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79280070 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79189312 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79187182 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.79059729 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79056984 |
| 88 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79001202 |
| 89 | Taste transduction_Homo sapiens_hsa04742 | 0.78248718 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77600319 |
| 91 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77231506 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76218473 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76111982 |
| 94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.74892520 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74569095 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73667952 |
| 97 | Olfactory transduction_Homo sapiens_hsa04740 | 0.73032962 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.72924272 |
| 99 | Measles_Homo sapiens_hsa05162 | 0.71922909 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.71800867 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71731572 |
| 102 | Melanoma_Homo sapiens_hsa05218 | 0.71372339 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71147972 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70943791 |
| 105 | Bladder cancer_Homo sapiens_hsa05219 | 0.70590576 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70577047 |
| 107 | Cocaine addiction_Homo sapiens_hsa05030 | 0.70408989 |
| 108 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68019084 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67522839 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66176713 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65859244 |
| 112 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.65753771 |
| 113 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.65643784 |
| 114 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65188003 |
| 115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65131016 |
| 116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64223240 |
| 117 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.63037654 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62092989 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62050299 |
| 120 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61372204 |
| 121 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.61030556 |
| 122 | Glioma_Homo sapiens_hsa05214 | 0.60162384 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59727050 |
| 124 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59044181 |
| 125 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58588725 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58187989 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57981682 |
| 128 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57956758 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.57386298 |
| 130 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57317417 |
| 131 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56089274 |
| 132 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55392545 |
| 133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54600462 |
| 134 | Insulin secretion_Homo sapiens_hsa04911 | 0.53373473 |
| 135 | GABAergic synapse_Homo sapiens_hsa04727 | 0.53034762 |
| 136 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52624453 |
| 137 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50855370 |
| 138 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50405803 |
| 139 | Ribosome_Homo sapiens_hsa03010 | 0.49845519 |
| 140 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49839819 |
| 141 | Salmonella infection_Homo sapiens_hsa05132 | 0.49783038 |
| 142 | Hepatitis B_Homo sapiens_hsa05161 | 0.47390391 |
| 143 | Axon guidance_Homo sapiens_hsa04360 | 0.44647906 |

